Intercept Pharmaceuticals Confirms Data Breach Resulting in Leaked SSNs, PHI and Financial Account Information

Console and Associates, P.C.

On February 22, 2024, Intercept Pharmaceuticals, Inc. (“Intercept”) filed a notice of data breach with the Attorney General of Massachusetts after discovering that an unauthorized party was able to access confidential information that had been entrusted to the company. In this notice, Intercept explains that the incident resulted in an unauthorized party being able to access consumers’ sensitive information, which includes their name, Social Security numbers, medical records, financial account information and driver’s license numbers. Upon completing its investigation, Intercept began sending out data breach notification letters to all individuals whose information was affected by the recent data security incident.

If you received a data breach notification from Intercept Pharmaceuticals, Inc., it is essential you understand what is at risk and what you can do about it. A data breach lawyer can help you learn more about how to protect yourself from becoming a victim of fraud or identity theft, as well as discuss your legal options following the Intercept Pharmaceuticals data breach. For more information, please see our recent piece on the topic here.

What Caused the Intercept Pharmaceuticals Data Breach?

The Intercept Pharmaceuticals data breach was only recently announced, and more information is expected in the near future. However, at this early stage in the investigation, Intercept’s filing with the Attorney General of Massachusetts provides only limited information on what led up to the breach. According to this source, we know that Intercept experienced a data security incident. Upon discovery, Intercept launched an investigation to learn more about the incident.

Ultimately, Intercept’s investigation confirmed that an unauthorized party was able to access certain files containing confidential consumer information.

After learning that sensitive consumer data was accessible to an unauthorized party, Intercept Pharmaceuticals reviewed the compromised files to determine what information was leaked and which consumers were impacted. While the breached information varies depending on the individual, it may include your name, Social Security number, medical records, financial account information and driver’s license number.

On February 22, 2024, Intercept Pharmaceuticals sent out data breach letters to anyone who was affected by the recent data security incident. These letters should provide victims with a list of what information belonging to them was compromised.

More Information About Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Morristown, New Jersey. Intercept focuses on the development and commercialization of therapeutics to treat rare and serious non-viral liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). Currently, Intercept has one product on the market; a PBC medication called Ocaliva. Intercept Pharmaceuticals employs more than 341 people and generates approximately $306 million in annual revenue.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Console and Associates, P.C. | Attorney Advertising

Written by:

Console and Associates, P.C.

Console and Associates, P.C. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide